105 related articles for article (PubMed ID: 26065263)
1. [EPHX1 Tyr113His polymorphism contributes to hepatocellular carcinoma risk: evidfnce from a meta-analysis].
Wang D; Zhai JX; Zhang LM; Liu DW; Liu XH
Mol Biol (Mosk); 2015; 49(2):351-61. PubMed ID: 26065263
[TBL] [Abstract][Full Text] [Related]
2. Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis.
Duan CY; Liu MY; Li SB; Ma KS; Bie P
Tumour Biol; 2014 Jan; 35(1):659-66. PubMed ID: 23955801
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma.
Zhong JH; Xiang BD; Ma L; You XM; Li LQ; Xie GS
PLoS One; 2013; 8(2):e57064. PubMed ID: 23451147
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between EPHX1 polymorphism and esophageal cancer risk: evidence from meta-analysis.
Yan YL; Chen X; Liang HJ; Wang J; Li TJ; Li RL; Li S; Qin X
Dis Esophagus; 2015; 28(2):164-71. PubMed ID: 25714851
[TBL] [Abstract][Full Text] [Related]
5. Systematic Review and Meta-Analysis of the Relationship between EPHX1 Polymorphisms and the Risk of Head and Neck Cancer.
Chen H; Ge L; Sui Q; Lin M
PLoS One; 2015; 10(4):e0123347. PubMed ID: 25923690
[TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.
Liu F; Yuan D; Wei Y; Wang W; Yan L; Wen T; Xu M; Yang J; Li B
PLoS One; 2012; 7(8):e43821. PubMed ID: 22928041
[TBL] [Abstract][Full Text] [Related]
7. Association between microsomal epoxide hydrolase 1 polymorphisms and susceptibility to esophageal cancer: a meta-analysis.
Zhao W; Luo J; Cai X
Tumour Biol; 2013 Aug; 34(4):2383-8. PubMed ID: 23681797
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of the effects of the EPHX1 Tyr113His polymorphism on lung and breast cancer.
Tan X; Wang YY; Chen XY; Xian L; Guo JJ; Liang GB; Chen MW
Genet Mol Res; 2014 Sep; 13(3):7437-46. PubMed ID: 25222243
[TBL] [Abstract][Full Text] [Related]
9. EPHX1 Tyr113His and His139Arg polymorphisms in esophageal cancer risk: a meta-analysis.
Tan X; He WW; Wang YY; Shi LJ; Chen MW
Genet Mol Res; 2014 Jan; 13(1):649-59. PubMed ID: 24615030
[TBL] [Abstract][Full Text] [Related]
10. Association between esophageal cancer risk and EPHX1 polymorphisms: a meta-analysis.
Li QT; Kang W; Wang M; Yang J; Zuo Y; Zhang W; Su DK
World J Gastroenterol; 2014 May; 20(17):5124-30. PubMed ID: 24803829
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis demonstrates lack of an association of microsomal epoxide hydrolase 1 polymorphisms with esophageal cancer risk.
Hu JJ; Wang ZT; Li B
Genet Mol Res; 2013 Oct; 12(4):4540-8. PubMed ID: 24222229
[TBL] [Abstract][Full Text] [Related]
12. Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma.
Tiemersma EW; Omer RE; Bunschoten A; van't Veer P; Kok FJ; Idris MO; Kadaru AM; Fedail SS; Kampman E
Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):785-91. PubMed ID: 11440964
[TBL] [Abstract][Full Text] [Related]
13. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis.
Xu Y; Li L; Xiang X; Wang H; Cai W; Xie J; Han Y; Bao S; Xie Q
Gene; 2013 Sep; 527(2):584-93. PubMed ID: 23791656
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
[TBL] [Abstract][Full Text] [Related]
15. The Tyr113His T/C rs1051740 and 'very slow' phenotype of the EPHX1 gene alters miR-26b-5p and miR-1207-5p expression in pregnancy.
Naidoo P; Naidoo RN; Ramkaran P; Asharam K; Chuturgoon AA
Gene; 2017 Oct; 633():71-81. PubMed ID: 28789952
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects.
Yang X; Wang Y; Wang G
J Exp Clin Cancer Res; 2014 Sep; 33(1):82. PubMed ID: 25261893
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
[TBL] [Abstract][Full Text] [Related]
18. Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viral-related hepatocellular carcinoma risk in India.
Kiran M; Chawla YK; Kaur J
DNA Cell Biol; 2008 Dec; 27(12):687-94. PubMed ID: 18816171
[TBL] [Abstract][Full Text] [Related]
19. EPHX1 gene polymorphisms in alcohol dependence and their distribution among the Indian populations.
Bhaskar LV; Thangaraj K; Patel M; Shah AM; Gopal K; Saikrishna L; Tamang R; Singh L; Rao VR
Am J Drug Alcohol Abuse; 2013 Jan; 39(1):16-22. PubMed ID: 22257321
[TBL] [Abstract][Full Text] [Related]
20. Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer.
Wang S; Zhu J; Zhang R; Wang S; Gu Z
Tumour Biol; 2013 Apr; 34(2):1045-52. PubMed ID: 23378225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
